Grid-based Integrated Bioinformatics Systems For High-Throughput Evolutionary Analysis of Genomes and Metabolic Networks

Monoclonal Antibody for Cancer Treatment

Ron Levy, MD, professor of Medicine at Stanford, recounts his experiences moving his discovery from the lab to the clinical setting and discusses the future of this cancer treatment. Wendy Harpham, a participant in the early clinical trials of Rituxan, the first FDA-approved monoclonal antibody for cancer treatment that Levy developed, provides a patient's perspective.

Biomolecular Simulation Lecture

This talk describes the current state of the art in biomolecular simulation and explore the potential role of high-performance computing technologies in extending current capabilities.

Lecture is Titled New architecture for New Biology Horizon,it talks about algorithms ,simulations involved proteomic studies especially molecular dynamics.this talks is view point of computer scientist who involved in creating alogrithms for biological sciences.so this lecture will very useful for bioinformaticians who are intersted in scripting.

The lecture starts with introduction about biochemistry and different types of protein structures (primary secondary,tertiary ).Talks about constraints in developing a three-dimensional structure(eventhough we know all amino acid structures) like identifying the fold region,binding region of proteins.

Next speaker talks about Molecular dynamics and its various algorithms involved in it.